DRKS00024800招募中不适用
Safety profile of COVID-19 vaccines and the comparison to COVID-19 symptomatology - ImpfSurv
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 7,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 105 Years（—）
- 性别
- All
入选标准
- •Included in the study are:
- •- Subjects 18 years of age and older
- •- Subjects who have received COVID-19 vaccination and have not had COVID-19.
- •- Subjects who have received COVID-19 vaccination and have had COVID-19.
- •- Subjects who had COVID-19 and were not vaccinated
- •- Subjects who have not had COVID-19 disease.
- •- Ability to give consent and signed informed consent form.
排除标准
- •Subjects without an understanding of the German language will be excluded from the study. Participants will also be excluded if they are participating or have participated in another (clinical) study that has not been completed 3 months prior to study participation.
研究者
相似试验
招募中
4 期
The safety and efficacy of COVID-19 vaccines among lung transplant recipientslung transplant recipientslung transplant, solid organ transplant, COVID-19JPRN-jRCT1021210009Okada Yoshinori80
已完成
4 期
The immune-response and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplantNL-OMON51071niversitair Medisch Centrum Groningen850
进行中（未招募）
1 期
The efficacy and safety of COVID-19 vaccination in patients with a kidney diseaseCOVID-19 is associated with increased morbidity and mortality in kidney transplant recipients (KTR) and patients with chronic kidneydisease (CKD). Therefore, potential efficacious SARS-CoV-2 vaccination would be of great clinical importance in these patients.However, SARS-CoV-2 vaccination studies have excluded KTR and patients with CKD so-far. This will be the subject of this trial.MedDRA version: 20.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10061105Term: DialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862MedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862MedDRA version: 23.0Level: LLTClassification code 10084462Term: SARS-CoV-2 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.0Level: LLTClassification code 10084463Term: SARS-CoV-2 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-000868-30-NLRECOVAC consortium850
已完成
1 期
Safety and Immunogenicity of EXG-5003.Prevention for SARS-CoV-2 infection diseaseJPRN-jRCT2041210013Doi Yohei60
进行中（未招募）
不适用
Immunogenicity and safety of COVID-19 vaccines in SLE and rheumatoid arthritis patientsSLERAImmunosuppresive agentsImmunogenicity to SARS-CoV2 vaccinationSLEImmunosuppressive therapyHumoral immune responseCellular immune responseSARS-CoV-2 vaccineRATCTR20210917003Ratchadapiseksompotch Fund, Faculty of Medicine100